Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Leena N. Alnsour"'
Autor:
Naser Al-Husban MD, FRCOG, Leena N. Alnsour, Zaid El-adwan, Nada A. Saleh, Mazen El-Zibdeh FRCOG
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Background: During pregnancy, the risk of venous thrombo-embolism (VTE) is increased at least five times compared with non-pregnant women of the same age, while the relative risk in the postpartum period can be as high as sixty times. The aim of the
Externí odkaz:
https://doaj.org/article/96bfc357b55f42ac8d5e300649bcfd39
Autor:
Nidaa A. Ababneh, Raghda Barham, Ban Al-Kurdi, Dema Ali, Nour Sharar, Sabal Al Hadidi, Renata M. Alatoom, Suzan Zalloum, Mohammad H. Gharandouq, Leen Makahleh, Leena N. Alnsour, Hebah Alshahwan, Mohammed El-Khateeb, Abdalla Awidi
Publikováno v:
Stem Cell Research, Vol 54, Iss , Pp 102358- (2021)
Limb-girdle muscular dystrophies (LGMDs) are a large group of heterogenous genetic diseases characterized by muscle weakness. In this study, an induced pluripotent stem cell (iPSC) line was generated from LGMD patient’s skin dermal fibroblasts, car
Externí odkaz:
https://doaj.org/article/e4748b2aaa1d4606b0fc01fe56462392
Autor:
Raghda Barham, Abdalla Awidi, Renata M. Alatoom, Ban Al-Kurdi, Suzan Zalloum, Mohammed El-Khateeb, Nidaa A. Ababneh, Sabal Al Hadidi, Mohammad H. Gharandouq, Dema Ali, Leen Makahleh, Leena N. Alnsour, Hebah Alshahwan, Nour Sharar
Publikováno v:
Stem Cell Research, Vol 54, Iss, Pp 102358-(2021)
Limb-girdle muscular dystrophies (LGMDs) are a large group of heterogenous genetic diseases characterized by muscle weakness. In this study, an induced pluripotent stem cell (iPSC) line was generated from LGMD patient’s skin dermal fibroblasts, car
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Background: During pregnancy, the risk of venous thrombo-embolism (VTE) is increased at least five times compared with non-pregnant women of the same age, while the relative risk in the postpartum period can be as high as sixty times. The aim of the
Publikováno v:
Clinical & Applied Thrombosis/Hemostasis; 2021, Vol. 27, p1-9, 9p